Teva introduces Testim generic

JERUSALEM — Teva on Wednesday announced the introduction of its generic of Testim (testosterone gel, 1%). The company received approval for the generic from the Food and Drug Administration in September.

Teva’s generic is available as 50 mg in a 5-gm tube. The product is indicated for testosterone replacement therapy in adult males for conditions associated with the deficiency or absence of endogenous testosterone. It carries a boxed warning for secondary exposure to testosterone.